Objective—To determine the effects of a dose of caffeine
(2.5 mg/kg, IV) administered to physically fit
Thoroughbreds during incremental exercise testing to
fatigue on a treadmill.
Animals—10 conditioned Thoroughbreds.
Procedure—Horses were randomly assigned to
receive caffeine or a control solution. Each horse
received both treatments in a crossover design with a
3-week interval between treatments. Each horse was
administered caffeine (2.5 mg/kg) or an equivalent
amount of a control solution IV. One hour after injection,
each horse performed an incremental exercise
test to exhaustion. Hematologic values, heart rate,
oxygen consumption, carbon dioxide production, plasma
lactate concentration, urine and serum concentrations
of caffeine and metabolites, and time until
exhaustion were monitored. Statistical analysis was
performed by use of a mixed-effects linear model.
Results—Significant differences in measured values
when horses were treated with caffeine or the control
solution were not detected.
Conclusions and Clinical Relevance—A dose of caffeine
(2.5 mg/kg, IV) appears to have no effect on any
performance variable of physically fit Thoroughbreds
during incremental exercise testing to fatigue. (Am J Vet Res 2005;66:569–573)
Objective—To evaluate the effects of a standardized exercise test to exhaustion in horses on leukocyte function ex vivo.
Animals—6 Thoroughbred geldings.
Procedures—Blood samples were obtained from each horse before exercise; at exhaustion (termed failure); and at 2, 6, 24, 48, and 72 hours after exercise to evaluate hematologic changes, rate of leukocyte apoptosis, and leukocyte production of reactive oxygen species (ROS) ex vivo. To assess leukocyte function, leukocyte ROS production in response to stimulation with lipopolysaccharide, peptidoglycan, zymosan, and phorbol myristate acetate was evaluated. Apoptosis was evaluated via assessment of caspase activity in leukocyte lysates.
Results—In response to lipopolysaccharide, production of ROS by leukocytes was significantly increased at 2 hours and remained increased (albeit not significantly) at 6 hours after exercise, compared with the preexercise value. In the absence of any stimulus, leukocyte ROS production was significantly increased at 6 and 24 hours after exercise. In contrast, ROS production in response to phorbol myristate acetate was significantly decreased at 6, 24, and 72 hours after exercise. Leukocyte ROS production induced by zymosan or peptidoglycan was not altered by exercise. Leukocytosis was evident for 24 hours after exercise, and neutrophilia was detected during the first 6 hours. A significant increase in the rate of leukocyte apoptosis was detected at failure and 72 hours after exercise.
Conclusions and Clinical Relevance—Results indicated that strenuous exercise undertaken by horses causes alterations in innate immune system functions, some of which persist for as long as 72 hours after exercise.